Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Efficacy and Safety of Monoclonal Antibodies Against Clostridioides difficile Toxins for Prevention of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.

Akiyama S, Yamada A, Komaki Y, Komaki F, Micic D, Sakuraba A.

J Clin Gastroenterol. 2020 Feb 12. doi: 10.1097/MCG.0000000000001330. [Epub ahead of print]

PMID:
32053529
2.

Systematic review with meta-analysis: risk of new onset IBD with the use of anti-interleukin-17 agents.

Yamada A, Wang J, Komaki Y, Komaki F, Micic D, Sakuraba A.

Aliment Pharmacol Ther. 2019 Aug;50(4):373-385. doi: 10.1111/apt.15397. Epub 2019 Jul 15. Review.

PMID:
31309607
3.

Cola Dissolution Therapy via Ileus Tube Was Effective for Ileus Secondary to Small Bowel Obstruction Induced by an Enterolith.

Komaki Y, Kanmura S, Tanaka A, Nakashima M, Komaki F, Iwaya H, Arima S, Sasaki F, Nasu Y, Tanoue S, Hashimoto S, Ido A.

Intern Med. 2019 Sep 1;58(17):2473-2478. doi: 10.2169/internalmedicine.2745-19. Epub 2019 May 22.

4.

A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease.

Anyane-Yeboa A, Yamada A, Haider H, Wang Y, Komaki Y, Komaki F, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A.

Aliment Pharmacol Ther. 2018 Nov;48(9):933-940. doi: 10.1111/apt.14951. Epub 2018 Aug 20.

5.

Gastrointestinal cancers in patients with cystic fibrosis - Authors' reply.

Yamada A, Komaki Y, Komaki F, Micic D, Zullow S, Sakuraba A.

Lancet Oncol. 2018 Aug;19(8):e369. doi: 10.1016/S1470-2045(18)30519-9. No abstract available.

PMID:
30102219
6.

Gastrointestinal cancer risk in cystic fibrosis: more exploration is needed - Authors' reply.

Yamada A, Komaki Y, Komaki F, Micic D, Zullow S, Sakuraba A.

Lancet Oncol. 2018 Jul;19(7):e333. doi: 10.1016/S1470-2045(18)30430-3. Epub 2018 Jun 29. No abstract available.

PMID:
30084376
7.

Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis.

Yamada A, Komaki Y, Komaki F, Micic D, Zullow S, Sakuraba A.

Lancet Oncol. 2018 Jun;19(6):758-767. doi: 10.1016/S1470-2045(18)30188-8. Epub 2018 Apr 26.

PMID:
29706374
8.

Risk of Fractures in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.

Komaki Y, Komaki F, Micic D, Ido A, Sakuraba A.

J Clin Gastroenterol. 2019 Jul;53(6):441-448. doi: 10.1097/MCG.0000000000001031.

PMID:
29672437
9.

The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.

Yamada A, Komaki Y, Patel N, Komaki F, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A.

Inflamm Bowel Dis. 2018 Feb 15;24(3):502-509. doi: 10.1093/ibd/izx054.

PMID:
29462385
10.

Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients-authors' reply.

Komaki Y, Yamada A, Komaki F, Sakuraba A.

Aliment Pharmacol Ther. 2017 Nov;46(9):905-906. doi: 10.1111/apt.14274. No abstract available.

11.

Firing rate estimation using infinite mixture models and its application to neural decoding.

Shibue R, Komaki F.

J Neurophysiol. 2017 Nov 1;118(5):2902-2913. doi: 10.1152/jn.00818.2016. Epub 2017 Aug 9.

12.

Risk of Colorectal Cancer in Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Komaki Y, Komaki F, Micic D, Ido A, Sakuraba A.

J Clin Gastroenterol. 2018 Oct;52(9):796-804. doi: 10.1097/MCG.0000000000000880.

PMID:
28723862
13.

Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.

Yamada A, Komaki Y, Patel N, Komaki F, Aelvoet AS, Tran AL, Pekow J, Dalal S, Cohen RD, Cannon L, Umanskiy K, Smith R, Hurst R, Hyman N, Rubin DT, Sakuraba A.

Am J Gastroenterol. 2017 Sep;112(9):1423-1429. doi: 10.1038/ajg.2017.201. Epub 2017 Jul 18.

PMID:
28719595
14.

Multivariate Time Series Decomposition into Oscillation Components.

Matsuda T, Komaki F.

Neural Comput. 2017 Aug;29(8):2055-2075. doi: 10.1162/NECO_a_00981. Epub 2017 May 31.

PMID:
28562213
15.

Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases - authors' reply.

Komaki Y, Yamada A, Komaki F, Micic D, Ido A, Sakuraba A.

Aliment Pharmacol Ther. 2017 May;45(10):1372. doi: 10.1111/apt.14060. No abstract available.

16.

Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment.

Hamasaki Y, Komaki F, Ishikura K, Hamada R, Sakai T, Hataya H, Ogata K, Ando T, Honda M.

Pediatr Nephrol. 2017 Aug;32(8):1383-1390. doi: 10.1007/s00467-017-3641-4. Epub 2017 Apr 4.

PMID:
28378029
17.

A point process modeling approach for investigating the effect of online brain activity on perceptual switching.

Matsuda T, Kitajo K, Yamaguchi Y, Komaki F.

Neuroimage. 2017 May 15;152:50-59. doi: 10.1016/j.neuroimage.2017.02.068. Epub 2017 Feb 24.

PMID:
28242318
18.

Systematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-α agent (infliximab), in inflammatory bowel diseases.

Komaki Y, Yamada A, Komaki F, Micic D, Ido A, Sakuraba A.

Aliment Pharmacol Ther. 2017 Apr;45(8):1043-1057. doi: 10.1111/apt.13990. Epub 2017 Feb 26. Review.

19.

Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis.

Komaki Y, Yamada A, Komaki F, Kudaravalli P, Micic D, Ido A, Sakuraba A.

J Autoimmun. 2017 May;79:4-16. doi: 10.1016/j.jaut.2017.02.003. Epub 2017 Feb 13. Review.

PMID:
28209290
20.

Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 Therapies.

Komaki Y, Komaki F, Yamada A, Micic D, Ido A, Sakuraba A.

Clin Pharmacol Ther. 2018 Feb;103(2):318-331. doi: 10.1002/cpt.633. Epub 2017 Oct 10.

PMID:
28118483
21.

Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis.

Komaki Y, Komaki F, Micic D, Ido A, Sakuraba A.

Gastrointest Endosc. 2017 Jul;86(1):93-104.e5. doi: 10.1016/j.gie.2016.12.009. Epub 2016 Dec 21. Review.

PMID:
28011280
22.

Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis.

Komaki Y, Komaki F, Micic D, Yamada A, Suzuki Y, Sakuraba A.

J Gastroenterol Hepatol. 2017 Jun;32(6):1143-1151. doi: 10.1111/jgh.13674.

PMID:
27957761
23.

Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-α use in females with immune mediated diseases; a systematic review and meta-analysis.

Komaki F, Komaki Y, Micic D, Ido A, Sakuraba A.

J Autoimmun. 2017 Jan;76:38-52. doi: 10.1016/j.jaut.2016.11.004. Epub 2016 Nov 30. Review.

PMID:
27913060
24.

Time Series Decomposition into Oscillation Components and Phase Estimation.

Matsuda T, Komaki F.

Neural Comput. 2017 Feb;29(2):332-367. doi: 10.1162/NECO_a_00916. Epub 2016 Nov 21.

PMID:
27870609
25.

High incidence of idiopathic nephrotic syndrome in East Asian children: a nationwide survey in Japan (JP-SHINE study).

Kikunaga K, Ishikura K, Terano C, Sato M, Komaki F, Hamasaki Y, Sasaki S, Iijima K, Yoshikawa N, Nakanishi K, Nakazato H, Matsuyama T, Ando T, Ito S, Honda M; Japanese Pediatric Survey Holding Information of NEphrotic syndrome (JP-SHINE) study of the Japanese Study Group of Renal Disease in Children.

Clin Exp Nephrol. 2017 Aug;21(4):651-657. doi: 10.1007/s10157-016-1319-z. Epub 2016 Sep 2.

PMID:
27590892
26.

Bayesian optimal response-adaptive design for binary responses using stopping rule.

Komaki F, Biswas A.

Stat Methods Med Res. 2018 Mar;27(3):891-904. doi: 10.1177/0962280216647210. Epub 2016 May 2.

PMID:
27142983
27.

Approach to Optimize Anti-TNF-α Therapy in Patients With IBD.

Komaki Y, Komaki F, Sakuraba A, Cohen R.

Curr Treat Options Gastroenterol. 2016 Mar;14(1):83-90. doi: 10.1007/s11938-016-0079-x.

PMID:
26872815
28.

Efficacy and Safety of Tacrolimus Therapy for Active Ulcerative Colitis; A Systematic Review and Meta-analysis.

Komaki Y, Komaki F, Ido A, Sakuraba A.

J Crohns Colitis. 2016 Apr;10(4):484-94. doi: 10.1093/ecco-jcc/jjv221. Epub 2015 Dec 8. Review.

29.

Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.

Inaba A, Hamasaki Y, Ishikura K, Hamada R, Sakai T, Hataya H, Komaki F, Kaneko T, Mori M, Honda M.

Pediatr Nephrol. 2016 Mar;31(3):425-34. doi: 10.1007/s00467-015-3174-7. Epub 2015 Sep 3.

PMID:
26335197
30.

A case of hereditary hemorrhagic telangiectasia with repeated hemobilia arrested by argon plasma coagulation under direct peroral cholangioscopy.

Komaki Y, Kanmura S, Funakawa K, Komaki F, Hashimoto S, Taguchi H, Numata M, Fujita H, Uto H, Ido A, Tsubouchi H.

Gastrointest Endosc. 2014 Sep;80(3):528-9. doi: 10.1016/j.gie.2014.04.022. Epub 2014 Jun 2. No abstract available.

PMID:
24890420
31.

Foxc1 gene null mutation causes ectopic budding and kidney hypoplasia but not dysplasia.

Komaki F, Miyazaki Y, Niimura F, Matsusaka T, Ichikawa I, Motojima M.

Cells Tissues Organs. 2013;198(1):22-7. doi: 10.1159/000351291. Epub 2013 Jul 3.

PMID:
23838094
32.

Effects of intravenous magnesium infusion on in vivo release of acetylcholine and catecholamine in rat adrenal medulla.

Komaki F, Akiyama T, Yamazaki T, Kitagawa H, Nosaka S, Shirai M.

Auton Neurosci. 2013 Oct;177(2):123-8. doi: 10.1016/j.autneu.2013.03.004. Epub 2013 Apr 3.

PMID:
23562142
33.

Characterization of ouabain-induced noradrenaline and acetylcholine release from in situ cardiac autonomic nerve endings.

Yamazaki T, Akiyama T, Kitagawa H, Komaki F, Mori H, Kawada T, Sunagawa K, Sugimachi M.

Acta Physiol (Oxf). 2007 Dec;191(4):275-84.

PMID:
17995575
34.

C1q nephropathy in a 2-year-old boy presenting with steroid resistant nephrotic syndrome.

Niimura F, Kamei A, Tamame T, Yamada K, Komaki F, Okamoto S, Matsuda S, Oh Y, Endoh M.

Tokai J Exp Clin Med. 2007 Sep 20;32(3):95-8.

35.

Information criteria for support vector machines.

Kobayashi K, Komaki F.

IEEE Trans Neural Netw. 2006 May;17(3):571-7.

PMID:
16722163
37.

The importance of postoperative choledochoscopy for management of retained biliary tract stones.

Yamakawa T, Komaki F, Shikata J.

Jpn J Surg. 1980 Dec;10(4):302-9.

PMID:
7218611
38.

Intrahepatic stones and postoperative choledochoscopy.

Yamakawa T, Komaki F, Kitano Y, Iizumi S, Shikata J.

Gastroenterol Jpn. 1980;15(6):577-83.

PMID:
7450389
39.

Experience with routine postoperative choledochoscopy via the T-tube sinus tract.

Yamakawa T, Komaki F, Shikata J.

World J Surg. 1978 May;2(3):379-85. No abstract available.

PMID:
706428
40.

Biliary tract endoscopy with an improved choledochofiberscope.

Yamakawa T, Komaki F, Shikata JI.

Gastrointest Endosc. 1978 Feb;24(3):110-3. No abstract available.

PMID:
631518
41.

[Case of cancer of the gastric cardia associated with para-esophageal hiatal hernia].

Saida Y, Kohno A, Kurosaki Y, Hiramatsu Y, Komaki F.

Rinsho Hoshasen. 1976 Oct;21(11):999-1004. Japanese. No abstract available.

PMID:
1034068

Supplemental Content

Loading ...
Support Center